Sector: MedicalTeva Pharmaceutical Industries (NASDAQ: TEVA)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 155 |
Technical : | 173 |
Performance : | 186 |
Overall: | 203 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 159 |
Technical : | 179 |
Performance : | 174 |
Overall: | 205 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 160 |
Technical : | 91 |
Performance : | 148 |
Overall: | 123 |
Number of Stocks: | 305 |
Headlines
- Trading Outlook for Novavax Inc. Issued by InvestorSoup.com
Nov 04, 2009 06:52 AM | MRK, NVAX, NVS, TEVA
- Antares Pharma to Present at the Merriman Investor Summit 2009
Nov 03, 2009 04:05 PM | AIS, TEVA
- Teva Introduces Fexofenadine HCl and Pseudoephedrine HCl Extended-Release Tablets; An Alternative to Allegra-D(R) 12 Hour Tablets
Nov 03, 2009 03:35 PM | SNY, TEVA
- Trading Outlook for Metabasis Therapeutics Issued by StockPreacher.com
Oct 29, 2009 06:52 AM | BIIB, GENZ, MBRX, TEVA
- Antares Pharma to Present at the 20th Annual Oppenheimer Healthcare Conference
Oct 27, 2009 05:05 PM | AIS, TEVA
- Cephalon Notified of Generic Filing for Armodafinil Tablets
Oct 21, 2009 04:06 PM | CEPH, TEVA
- Teva Comments on Positive Results of Phase III Trial in MediWound's Debrase(R)
Oct 20, 2009 03:17 PM | TEVA
- Teva Comments on Mylan Paragraph IV Filing for COPAXONE(R); Files Lawsuit against Generic Filer for Patent Infringement
Oct 16, 2009 05:11 PM | TEVA
- Teva to Report Third Quarter 2009 Financial Results on November 3, 2009
Oct 15, 2009 12:30 PM | TEVA
- Larry King to Host 10th Annual American Friends of Rabin Medical Center 'Broadway on the Hudson' Gala
Oct 15, 2009 10:00 AM | TEVA
- Lawyers target Israeli medical supplier
Oct 13, 2009 01:25 PM | TEVA
- Business Highlights
Aug 19, 2009 06:50 PM | BJ, DE, MRK, TEVA, WFC
- Teva Q2 Net Income Decreases
Jul 29, 2009 05:50 AM | TEVA
- Women underestimate menopause symptoms
Jul 15, 2009 06:42 PM | TEVA
- Teva and Antares Win FDA Approval for Needle-Free Device
Jun 30, 2009 12:56 PM | TEVA
- Teva Q1 Net Income Surges
May 06, 2009 04:00 AM | TEVA
- COPAXONE(R) Approved By Health Canada for Patients With Clinically Isolated Syndrome (CIS) Suggestive of Multiple Sclerosis (MS)
Apr 16, 2009 05:53 PM | TEVA
- Cubist Files Patent Infringement Lawsuit Against Teva Parenteral Medicines
Mar 24, 2009 01:02 PM | CBST, TEVA
- BRIEF: Bedford Employer Named Israel's Strongest Company
Jan 15, 2009 01:21 PM | DNB, TEVA
- BRIEF: Teva Pharmaceutical Industries Receives Approval to Buy Barr Laboratories in Forest
Dec 20, 2008 10:13 AM | BRL, TEVA
- Teva Introduces Fexofenadine HCl and Pseudoephedrine HCl Extended-Release Tablets; An Alternative to Allegra-D® 12 Hour Tablets
Nov 03, 2009 03:54 PM | TEVA
- Teva Reports Third Quarter 2009 Results
Nov 03, 2009 01:52 AM | TEVA
- MichBio Expo &Amp; Conference Exhibitors Profiled
Oct 27, 2009 11:53 AM | ENL, PFE, TEVA
- Teva Comments on Mylan Paragraph IV Filing for COPAXONE®; Files Lawsuit Against Generic Filer for Patent Infringement
Oct 16, 2009 05:52 PM | MNTA, MYL, TEVA
- Teva Provides Update on Generic Seroquel® Litigation
Sep 25, 2009 04:51 PM | AZN, TEVA
- Teva Provides Update on Generic Evista® Litigation
Sep 24, 2009 06:54 AM | LLY, TEVA
- Teva Women's Health Announces CopewithMenopause.Com Relaunch Just in Time for Menopause Awareness Month ; New Design Features Dynamic Content Including Videos and Resources to Help Women and Their Families Deal With the Impact of Menopause
Sep 09, 2009 10:52 AM | TEVA
- The First Israel Fund, Inc. Announces Performance Data and Portfolio Composition
Sep 02, 2009 03:52 PM | PRGO, TEVA
- Teva Provides Update on Generic Singulair® Litigation
Aug 19, 2009 11:52 AM | TEVA
- StockPreacher.com Issues Trading Outlook for Cell Therapeutics Inc.
Aug 19, 2009 06:51 AM | CTIC, GILD, TEVA
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
TEVA
|
Compare to S&P
|
| YTD |
18.58 %
|
3.37 %
|
| 4 Weeks |
0.80 %
|
-0.27 %
|
| 12 Weeks |
-2.40 %
|
-4.82 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 16.90 %
|
|
EPS Growth in Last Year: 27.69 %
|
|
Sales Growth in Last Quarter: 8.04 %
|
|
Sales Growth in Last Quarter: 20.44 %
|
|
